On the other hand, in IgA nephropathy (IgAN) patients, Wang et al. showed that corticosteroid treatment of patients with IgAN significantly reduced the percentage of circulating ICOS+PD-1hiCXCR5− T cells (cTFh cells) [53]. This evidence concerns the gene ICOS and IgA glomerulonephritis.